In 2006, Kirschner et al. 21 introduced the use of human acellular dermal matrices for oronasal fistula repair. The authors observed the ingrowth of fibrovascular tissue and complete fistula closure in nine patients.
Another biomaterial suitable for oronasal fistula repair might be amniotic membrane, which is easily available and reasonably priced with regard to its harvesting and processing to a medical product (e.g., testing for viral infections of the donors and cryoconservation). Amniotic membrane is the inner layer of the fetal membranes and has been investigated as an alternative biomaterial for various purposes in reconstructive surgery since its initial description as a material suitable for transplantation in 1910. 22 It offered new perspectives, for example, in the treatment of burn wounds. 23 Interest in human amniotic membrane diminished as a consequence of emerging awareness of human immunodeficiency virus and the fear of virus transmission in the 1980s. The end of the 1990s saw the establishment of new methods for the processing and long-term storage (such as cryoconservation) of human amniotic membrane, and its use in reconstructive surgery became popular again. 24 However, the material is thin and lacerable, and its use in the oral cavity is challenging (e.g., because of forces caused by the tongue and food particles).
We recently investigated the suitability of xenogenous human amniotic membrane for the repair of oronasal fistula in a porcine model and obtained promising results. 25 The aim of the present study was to expand our knowledge of this material as follows: (1) by evaluating the adequacy of the tensile strength of human and porcine amniotic membrane when arranged in the multilayer technique; (2) by evaluating amniotic membrane allograft for oronasal fistula repair in a porcine model and investigating possible advantages of autofetal amniotic membrane (i.e., the "autologous" amniotic membrane of a fetus harvested at its birth) (as a control, a resorbable, extracellular matrix scaffold material, termed "small intestinal submucosa," was also evaluated); and (3) by transference to clinical practice in an initial small series of patients.
METHODS

Porcine and Human Amniotic Membrane
Experiments on animals were conducted in accordance with German governmental regulations for animal welfare and with approval of the District Council (no. 55.2-1-54-2531-183-09; April 26, 2010). Porcine amniotic membrane was harvested during porcine cesarean delivery carried out under general anesthesia, in the Clinic for Swine of Ludwig-Maximilians-University Munich. The membranes were separated from the piglets on their removal from the uterus under sterile conditions (Fig. 1 ), transferred to a sterile laminar flow hood (Herasafe; Kendro, Langenselbold, Germany), cut into 5 × 5-cm pieces, and applied to nitrocellulose sheets (Raucocel; Lohmann-Rauscher, Rengsdorf, Germany). Each sheet was stored in a 50-ml sterile tube (Falcon; BD Biosciences, San Jose, Calif.) containing medium for cryoconservation consisting of 250 ml of glycerin, 250 ml of Dulbecco's Modified Eagle Medium (JR Scientific, Woodland, Calif.), 5 ml of penicillin/streptomycin solution, and 5 ml of amphotericin B solution (Merck, Darmstadt, Germany). The tubes were stored at −80°C and thawed for 30 minutes before usage in a 28°C water bath.
The study protocols for the use of human amniotic membrane in human patients were approved by the District Council and the local ethics committee (no. 3071/10; February 1, 2011). Operations were carried out in accordance with the Declaration of Helsinki. All patients gave written informed consent. Human amniotic membrane allografts were fabricated in cooperation with the Red Cross Transfusion Service of Upper Austria, Linz, Austria, as a certified medical product at a size of 4 × 4 cm. This size was determined in unpublished internal studies to ideally meet the requirements of reconstructive surgery in the oral cavity. Agglutination tests were performed for human immunodeficiency virus (anti-HIV), hepatitis C (anti-HCV), hepatitis B (anti-HBc, HB-Ag), and cytomegalovirus (anti-CMV-IgG/-IgM); Treponema pallidum hemagglutination and enzyme-linked immunosorbent assay tests were performed for syphilis; and polymerase chain reaction tests were performed for human immunodeficiency virus, hepatitis C virus, and human papilloma virus.
Part A: Laboratory Experiment
Uniaxial forces needed for the rupture of onelayer, two-layer, and four-layer human and porcine amniotic membranes were evaluated by fixing the membranes on a standardized square field (3 × 3 cm) in a digitally controlled towing device (model 100kN; Zwick, Ulm, Germany) (Fig. 2) . Computer software determined the maximal force applied until rupture. The first test series consisted of 20 repeats for each one-layer, twolayer, and four-layer porcine membrane. In the second series, the experiment was repeated with human amniotic membrane.
Statistical Analysis of Laboratory Experiment
IBM SPSS 19.0 software (SPSS, Inc., Chicago, Ill.) was used. Differences with respect to the forces needed for membrane rupture were analyzed by using the Mann-Whitney U test. All p values are given as two-tailed with a local significance level of 5 percent.
Part B: Animal Experiment
Animals and Defect Preparation Twenty-four 8-week-old piglets ("Schwaebisch Haellische" × "Pietrain" hybrids, 22 to 32 kg; kept according to the international principles of laboratory animal care) were used. All were born by cesarean delivery from the same dam in the Clinic for Swine of Ludwig-MaximiliansUniversity, Munich. Their amniotic membrane was harvested and stored as autofetal amniotic membrane. Amniotic membrane allografts were collected from another dam. Water and food were given freely. Oronasal fistulas were produced under general anesthesia. To induce anesthesia, 10 mg/kg body weight ketamine (Ursotamin; Serum-Werk, Bernburg, Germany) and 2 mg/ kg azaperone (Stresnil; Janssen-Cilag, Neuss, Germany) were administered intramuscularly. Animals were intubated, and anesthesia was maintained with 1 to 2 percent isoflurane (Isoba; Intervet, Unterschleissheim, Germany) and 3 to 5 liters/minute oxygen. Piglets were placed on their back. Silicon dental casts of the palates were taken before fistulas were made in order to manufacture individual protection plates for coverage of the defects after repair. The plates were manufactured in the Laboratory of the Technische Universität München and consisted of polymethylmethacrylate. In each piglet, a full-thickness defect in the mid-hard palate of ~15 mm in diameter was produced with a biopsy punch and subsequent watercooled osteotomy of the hard palate (Fig. 3) . The nasal septum and edges of the bony palate were rongeured beyond the mucosal edges to allow for re-epithelialization at the periphery of the defects. Fistulas matured for 2 weeks. After this time, all fistulas were persistent and re-epithelialized at their margins.
Fistula Repair
Six animals were randomly selected to have their fistulas repaired with allografts of fivelayer amniotic membrane, six were treated with five-layer autofetal amniotic membrane, and six received small intestinal submucosa (Cook Group Inc., Bloomington, Ind.). Multilayered amniotic membrane was prepared as previously described. 26 Grafts were interposed between the oral and nasal mucosa traversing the palatal fistulas and sutured with polyglactin (Vicryl 4-0; Ethicon, Norderstedt, Germany) to the lateral edges of the mucoperiosteal bilateral flap created according to the von Langenbeck technique (Fig. 4) . Mucosal edges of the fistulas were Uniaxial forces needed for rupture of one-, two-, and fourlayer human and porcine amniotic membrane were evaluated by fixing the membranes on a standardized test field with a width of 3 cm in a digitally controlled towing device (model 100 kN; Zwick, Ulm, Germany). The lower part of the image shows an example of a single-layer amniotic membrane adapted to the immobile metal plate of the machine. Membranes were subsequently fixed to this plate by the addition of a second metal plate that was tightened against the first plate. The clamp in the upper half of the image was connected to the mobile part of the towing machine and pulled the membrane upward once the experiment was initiated. Forces needed until rupture were digitally recorded by computer software.
not closed. The prefabricated protective plates were placed onto the palates and fixed with two 13-mm screws in order to protect the transplants from mechanical damage (Fig. 5 ). Wounds were monitored by photodocumentation on postoperative days 3, 7, 10, and 76 under short sedation. They were cleaned of blood clots and food pellets after removal of the palatal protective plates, which were refixed until they were ultimately removed on day 10. Wound monitoring involved the assessment of local inflammation by visual grading of the degree of redness around the fistula (0 = none; 1 = moderate; 2 = pronounced) in the photographs, which were scored independently by two blinded investigators. On day 76, the pigs were euthanized by sedation and intravenous administration of 45 mg/kg pentobarbital (Release; WdT, Garbsen, Germany). A final evaluation of the palates for remaining fistulas was performed with a probe, and the palates were removed and stored in formalin (3.7 percent) for microscopic analyses.
Histological Analysis
Samples were embedded in paraffin, and 4-µm-thick sections were cut with a microtome (Hyrax M 55; Zeiss, Jena, Germany). Paraffin was extracted, and sections were stained with hematoxylin and eosin (Bio Optica, Milan, Italy) and analyzed with a microscope (AxioCam HRC; Zeiss). A closed oral and nasal epithelium with no fistula remnants and no signs of inflammation was regarded as the preferred result. Microscopic evaluation of the former defect region on day 76 was carried out in order to confirm the clinical results with respect to closure of the oral epithelium and to investigate the closure of the nasal defects and the presence of fistula tract remnants on either side of the nasal septum. Accordingly, two regions were evaluated in each animal, Fig. 3 . Creation of iatrogenic oronasal fistula in the porcine palate. The animal had previously been intubated and placed on its back, with its tongue fixed to the lower jaw. The nasal septum is visible in the middle of the fistula. The marginal bone was removed in an undermining manner to allow epithelial growth over the defect margins from both the palatine and the nasal side of the fistula. In this manner, so-called critical-size defects were created, which showed no tendency for spontaneous healing. The defects were allowed to mature for 2 weeks and were subsequently repaired with multilayered amniotic membrane allograft, autofetal amniotic membrane, or small intestinal submucosa. resulting in a total of 12 areas of interest in each group. All stainings were produced in duplicate and scored independently by two blinded investigators.
Part C: Clinical Trial
Four patients (two women and two men, ages 21 to 51 years) diagnosed with oronasal fistula of the hard palate were treated with multilayered amniotic membrane allografts (three in Munich, one in Linz). After defect preparation (removal of epithelium covering the fistula margins), amniotic membrane was fixed to the marginal oral epithelium (the fistula edges were freshened and the amniotic membrane was sewn to the nasal epithelium and subsequently to the oral mucosa) (Fig. 6,  above) . In none of the four patients could the defect be closed primarily or by local flaps. The von Langenbeck technique was not used in the patients in an attempt to reduce local tissue trauma. Protective plates were inserted for transplant protection in each patient (Fig. 6,  center) . The plates were produced as follows: dental models of the maxilla were produced by obtaining impressions in alginate (Palgat; 3M, Neuss, Germany) and filling them with gypsum. Fistulas were closed in the models with dental wax in order to simulate the postoperative situation. Polymethylmethacrylate plates (Biocryl; Scheu, Iserlohn, Germany) were heated and suctioned over the models in a vacuum device (Twinstar; Scheu), as recommended by the manufacturer. After the plates cooled down, their edges were shortened in order to avoid gingival trauma.
RESULTS
Part A: Laboratory Experiment
Single-layered human amniotic membrane exhibited a median tensile strength of 3.46 N until rupture (mean, 3.563 N; minimum, 1.23 N; maximum, 6.04 N). Double-layered human membrane showed a median tensile strength of 8.455 N (mean, 9.283 N; minimum, 3.05 N; maximum, 16.25 N), which was higher than that of single-layered membrane (p < 0.001). Four-layer membrane exhibited a median tensile strength of 18.9 N (mean, 18.825 N; minimum, 11.29 N; maximum, 22.66 N), which was higher than that of double-layered membrane (p<0.001).
Single-layered porcine amniotic membrane exhibited a median tensile strength of 1.745 N until rupture (mean, 1.776 N; minimum, 0.8 N; maximum, 2.97 N). Double-layered porcine membrane showed a median tensile strength of 3.82 N (mean, 4.566 N; minimum, 1.52 N; maximum, 9.41 N), which was higher than that of single-layered membrane (p < 0.001). Four-layered membrane exhibited a median tensile strength of 9.94 N (mean, 10.527 N; minimum, 6.04 N; maximum, 17.03 N), which was significantly higher than that of double-layered membrane (p < 0.001).
Forces needed for the rupture of human amniotic membrane were higher than those needed for porcine amniotic membrane in each one-, two-, and four-layer technique (p < 0.001).
Part B: Animal Experiment
Clinical Course All animals survived with no signs of illness. All oronasal fistulas showed marginal re-epithelialization and no tendency for spontaneous closure at 2 weeks after their creation.
All oronasal fistulas treated with amniotic membrane allograft and autofetal amniotic membrane showed similar wound healing. On day 7, amniotic membrane was no longer recognizable because of the overgrowth of granulating tissue and fibrin covering. Three of six fistulas in the allograft group and five in the autofetal group were completely closed on day 10. In both groups, all fistulas were completely closed and showed no signs of inflammation on day 76 (Fig. 7) . All animals in both groups showed moderate local redness on day 3; this increased in three cases in each group on day 7. A single animal showed moderate local redness on day 10, and no inflammation was observed in any animal in either group on day 76 (Fig. 8) . Thus, no difference in clinical course was observable between the animals treated with amniotic membrane allograft or autofetal amniotic membrane.
No small intestinal submucosa was recognizable in animals treated with this material on the seventh postoperative day. One fistula was completely closed on day 10, and five of the six animals showed a completely closed oral epithelium on day 76. In the remaining case, a persistent fistula was found with a probe. Local redness was comparable with that of the amniotic membrane groups. Pronounced redness was seen in four animals on day 3 and one animal on day 7 (five with moderate inflammation). Four animals exhibited moderate redness on day 10, and no signs of inflammation were observed on day 76.
Histologic Analysis
Histologic analysis confirmed the clinical observation of completely closed oral epithelium in all samples from both the allograft and the autofetal amniotic membrane groups. Two animals treated with allograft exhibited unilateral fistula tract remnants, and two exhibited bilateral remnants. Three cases of unilateral remnants were found in the autofetal group (Fig. 9) , each with histologic signs of mild chronic inflammation on the nasal side. All fistula tract remnants were covered with respiratory epithelium.
All of the animals treated with small intestinal submucosa showed at least unilateral nasal fistula tract remnants. In four cases, remnants were found bilaterally, and in one case, the oral epithelium was not closed, indicating a persisting oronasal fistula. In all but one animal, signs of mild chronic inflammation were evident, and fibrosis occurred in four of these five cases. Table 1 provides an overview of the histological results and details regarding signs of inflammation and fibrosis.
Part C: Clinical Trial
All patients showed complete closure of the oral epithelium with no signs of inflammation during the follow-up period (Fig. 6, below) .
DISCUSSION
Surgical closure of a cleft palate is intended to establish an intact separation between the oral and nasal cavities. Because of frequent limitations in the amount of local tissues and scarring after previous surgical procedures, the formation of an oronasal fistula is a common complication. 27 Prognosis for successful closure declines with further attempts at surgical correction. 28 A multitude of closure techniques have been suggested, such as mucoperiosteal flaps, 29 pedicled tongue flaps, 30 and free flaps, 20 but many methods can cause donor-site morbidity. 21, 31 The use of an external biomaterial might represent one way to preserve healthy tissue without the limitations in local quantity and restrictions caused by cicatrization. Donor-site morbidity can be avoided by the use of alternative biological materials. Biomaterials have become popular in head and neck reconstructive surgery, but only a few publications report their use in oronasal fistula closure.
Acellular dermal matrices were introduced for the closure of palatal clefts in 2003. 32 Kirschner et al. 21 described oronasal fistula repair with acellular dermal matrices. In a swine model in the first part of the study and in a clinical trial with nine patients in the second part, the authors achieved convincing results. Complete fistula closure was observed in all patients, despite two patients initially presenting with a dehiscence. Aldekhayel et al. 33 investigated the available evidence for the usage of acellular dermal matrix in cleft palate repair. The authors concluded that the use of acellular dermal matrices may reduce fistula formation and fistula persistence in palate surgery, but they pointed out that prospective, randomized studies are necessary.
Ophof et al. investigated other biomaterials for the reconstruction of palatal defects in dogs, such as tissue-engineered mucosal substitutes containing oral keratinocytes 34 or scaffolds of cross-linked bovine tendon collagen and glycosaminoglycans. 35 Transplant loss and cell degradation were observed in the former study.
Amniotic membrane is currently used for reconstruction of the ocular surface, 36 abdominal wall, 26 urinary bladder, 37 leg ulcers, 38 and burns. 39 It exhibits anti-inflammatory effects and has low immunogenicity. 40 This study reports the first The axis of the ordinates shows the mean degree of local redness in all animals of a group. The axis of the abscissas displays postoperative days (POD) 3, 7, 10, and 76. Although no statistical analysis was carried out because of the small sample size, the diagram indicates that no clinically relevant difference was present in the rate of infections among the groups with amniotic membrane allograft, autofetal amniotic membrane (which showed exactly the same postoperative course with respect to local redness), and small intestinal submucosa, although the local signs of inflammation were slightly higher in the small intestinal submucosa group on postoperative days 3 and 10. clinical use of amniotic membrane allografts and autofetal amniotic membrane for oronasal fistula repair. Complete fistula closure was observed after transplantation of multilayered autofetal amniotic membrane or amniotic membrane allograft in the animal experiment. No relevant immune reaction or reduced signs of inflammation compared with the group treated with small intestinal mucosa were noted on postoperative days 3 and 10.
The treatment of patients with amniotic membrane gave excellent results: all fistulas were closed with no signs of inflammation. The results demonstrate that transplantation of autofetal amniotic membrane or amniotic membrane allografts represents an interesting new method for oronasal fistula closure. A potential disadvantage might be the need to fabricate protective plates in order to avoid mechanical damage, but their use and the multilayer technique have solved the previously reported problem of mechanical instability of amniotic membrane. 37 This study has demonstrated that the stability of an amniotic membrane transplant can be increased by using additional layers.
One interesting opportunity is the storage of autofetal amniotic membrane. Children who are prenatally diagnosed with a cleft palate can later be treated with their own amniotic membrane. Oronasal fistulas are usually not repaired during the infant stage, but cryoconserved amniotic membrane can be stored and later used as an exclusive biomaterial for reconstructive surgery. It can also be used in case of burn wounds or other trauma. The procedures for harvesting and cryoconservation and the clinical use of autofetal amniotic membrane are offered to parents expecting a child diagnosed with a cleft palate.
A drawback of this study is the small number of clinical cases. However, the results of the first patients treated with this method emphasize the encouraging findings from the earlier experimental study arm. A randomized trial with a larger number of cases is necessary to validate these initial results.
CONCLUSIONS
Amniotic membrane is useful for oronasal fistula repair. It prevents donor-site morbidity and is easy to harvest, economically reasonable, and available in large quantities. The multilayer technique and protective plates solve the problem of mechanical instability. It is now possible to harvest and store the autofetal amniotic membrane of a child with a cleft palate as an exclusive tissue source for later reconstruction. Amniotic membrane allografts can be used without noticeable disadvantages when compared with autofetal amniotic membrane, which is relevant for patients with no reserves of autofetal amniotic membrane. 
